DCOY Decoy Therapeutics Inc. - Common Stock
NASDAQ · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 12, 2026
$1.77
· of 52w range
· above low
· to high
$0.5252w low
$13.5152w high
Market Cap (MRQ)
$941.6K
P/E
-0.0
EPS
$-129.10
your badges
52W Range
$1–$14
Analyst Rating
HOLD
Price Target
$3
P/E
-0.0
ROE
·
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
DCOY Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$1.77
Market Cap (MRQ)
$941.6K
P/E
-0.0
EPS
$-129.10
52W Range
$1–$14
DCOY Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| March 9, 2026 | 1-for-12 | Reverse |
| Aug. 18, 2025 | 1-for-15 | Reverse |
| June 17, 2024 | 1-for-8 | Reverse |
| Oct. 17, 2022 | 1-for-25 | Reverse |
| July 22, 2019 | 1-for-25 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue·2016-12-31 → 2022-12-31
EPS$-129.102020-12-31 → 2025-12-31
Free Cash Flow·2016-12-31 → 2021-12-31
Net margin·2016-12-31 → 2021-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | DCOY | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -0.0 | · | · | · | |
| P/B (MRQ) | 0.2 | · | · | · | |
| Price / Tangible Book | 0.1 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | DCOY | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 1.8 | · | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
50.4%
Next Report
Nov 12, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| Sept. 30, 2024 | $-136.80 | $-440.64 | 69.0% | |
| March 31, 2024 | $-590.40 | $-9840.96 | 94.0% | |
| Sept. 30, 2023 | $-936.00 | $-1762.56 | 46.9% | |
| June 30, 2023 | $-2059.20 | $-1904.55 | -8.1% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | $0 | $2M | $5M | $3M | $2M | $1M | $1M | $0 | $0 | |
| Cost of Revenue | · | · | · | · | · | · | · | $430.8K | $506.5K | $662.7K | $0 | $0 | |
| R&D Expense | $368.2K | $770.0K | $7M | $16M | $9M | $7M | $4M | $1M | $17M | $20M | $13M | $4M | |
| SG&A Expense | $4M | $5M | $6M | $7M | $6M | $6M | $8M | $2M | $19M | $20M | $16M | $4M | |
| Operating Expenses | $13M | $6M | $13M | $32M | $15M | $13M | $12M | $4M | $36M | $41M | $29M | $8M | |
| Operating Income | $-13M | $-6M | $-13M | $-32M | $-13M | $-8M | $-8M | $-2M | $-35M | $-40M | $-29M | $-8M | |
| Interest Income | · | · | · | · | · | · | · | $152.0K | $292.0K | $393.1K | $72.0K | $18.9K | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | $-29M | $-8M | |
| Income Tax | $0 | · | · | · | · | · | $0 | · | · | · | · | · | |
| Net Income | $-13M | $-6M | $-13M | $-32M | $-13M | $-7M | $-7M | $-2M | $-34M | $-39M | $-29M | $-8M | |
| EPS (Basic) | $-129.10 | $-69.54 | $-30.74 | $-14.88 | $-7.72 | $-0.50 | · | · | · | · | · | · | |
| EPS (Diluted) | $-129.10 | $-69.54 | $-30.74 | $-14.88 | $-7.72 | $-0.50 | · | · | · | · | · | · | |
| Shares (Basic) | 96,967 | 80,184 | 408,078 | 2,124,511 | 1,654,638 | 15,578,611 | · | · | · | · | · | · | |
| Shares (Diluted) | 96,967 | 80,184 | 408,078 | 2,124,511 | 1,654,638 | 15,578,611 | · | · | · | · | · | · | |
| EBITDA | · | $-6M | · | $-32M | $-13M | $-8M | $-8M | · | $-35M | $-40M | · | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $11M | $2M | $6M | $12M | $29M | $11M | $4M | $3M | $19M | $22M | $67M | $34M | |
| Short-term Investments | · | · | · | · | · | · | · | $0 | $14M | $39M | $25M | $0 | |
| Receivables | · | · | · | · | $2M | $4M | $0 | $9.9K | $10.4K | $12.2K | $0 | · | |
| Inventory | · | · | · | · | · | · | · | $186.9K | $431.9K | $454.1K | $0 | · | |
| Prepaid Expense | $275.2K | $553.0K | $619.8K | $803.4K | $949.2K | $822.0K | $955.9K | $249.1K | $777.1K | $926.0K | $908.6K | $370.4K | |
| Other Current Assets | $275.2K | $43.7K | $151.3K | $167.6K | $173.0K | $137.8K | $136.1K | $22.3K | · | · | · | · | |
| Current Assets | $11M | $3M | $7M | $15M | $30M | $16M | $5M | $6M | $35M | $62M | $92M | $34M | |
| PP&E (Net) | $40.6K | $0 | · | · | $7.9K | $22.6K | $25.0K | $37.5K | $331.0K | $556.3K | $382.4K | $85.1K | |
| PP&E (Gross) | · | · | · | · | · | · | · | $875.6K | $953.9K | $879.3K | $442.5K | $97.1K | |
| Accum. Depreciation | · | · | · | · | · | · | · | $801.1K | $622.9K | $323.0K | $60.1K | $12.0K | |
| Goodwill | · | · | · | $0 | $9M | $9M | $9M | $0 | · | · | · | · | |
| Other Non-current Assets | $31.0K | $35.4K | $66.8K | $130.5K | $193.9K | $247.1K | $308.7K | $195.4K | $0 | $64.8K | $0 | $50.0K | |
| Total Assets | $11M | $3M | $7M | $15M | $41M | $25M | $14M | $7M | $35M | $63M | $95M | $36M | |
| Accounts Payable | $940.6K | $937.0K | $602.9K | $3M | $2M | $2M | $2M | $379.8K | $2M | $1M | $875.6K | $578.7K | |
| Short-term Debt | $0 | $221.9K | $289.6K | $0 | $0 | $477.0K | $502.3K | $0 | · | · | · | · | |
| Current Liabilities | $5M | $2M | · | · | · | · | · | $1M | $6M | $4M | $3M | $1M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | $0 | $15.4K | $15.4K | |
| Total Liabilities | $5M | $2M | $1M | $4M | $2M | $3M | $3M | $8M | $6M | $4M | $3M | $1M | |
| Total Debt | · | $221.9K | · | · | $0 | $477.0K | $502.3K | · | · | · | · | · | |
| Common Stock | $53 | $1 | $49 | $225 | $181 | $2.4K | $451 | $203 | $1.8K | $1.7K | $1.6K | $221 | |
| Paid-in Capital | $100M | $83M | $82M | $74M | $71M | $42M | $23M | $4M | $140M | $136M | $129M | $1M | |
| Retained Earnings | $-94M | $-82M | $-76M | $-64M | $-32M | $-19M | $-12M | $-5M | $-111M | $-77M | $-37M | $-8M | |
| AOCI | · | · | · | · | · | · | · | $0 | $-1.2K | $-1.6K | $-24.7K | $0 | |
| Stockholders' Equity | $6M | $2M | $5M | $10M | $39M | $22M | $11M | $-1M | $-3M | $59M | $92M | $-7M | |
| Liabilities + Equity | $11M | $3M | $7M | $15M | $41M | $25M | $14M | $7M | $35M | $63M | $95M | $36M | |
| Shares Outstanding | 531,968 | 8,006 | 2,735 | 281,987 | 1,809,593 | 23,808,546 | 4,511,174 | 2,032,763 | 1,178,604 | 16,773,798 | 15,741,618 | 2,215,711 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $7.2K | $4.4K | $10.1K | $6.7K | $19.2K | $18.1K | $127.4K | $16.9K | · | · | · | · | |
| Stock-based Comp | $219.1K | $273.7K | $524.8K | $796.8K | $559.0K | $319.4K | $751.6K | $31.0K | $4M | $7M | $7M | $1M | |
| Restructuring | · | · | · | · | · | · | · | $1M | · | · | · | · | |
| Other Non-cash | · | $772.3K | · | $13M | $2M | $-3M | $-6M | · | · | · | · | · | |
| Operating Cash Flow | $-5M | $-5M | $-13M | $-18M | $-10M | $-10M | $-12M | $4M | $-28M | $-32M | $-21M | $-6M | |
| CapEx | $577.0K | $0 | · | · | $0 | $2.6K | $0 | $0 | $113.5K | $559.4K | $265.6K | $76.1K | |
| Investing Cash Flow | $764.7K | $0 | $0 | $-2M | $0 | $-2.6K | $6M | $0 | $24M | $-12M | $-27M | $-76.1K | |
| Stock Issued | · | · | · | · | · | · | · | $3M | · | · | · | · | |
| Dividends Paid | · | · | · | · | · | $0 | $133.6K | $0 | · | · | · | · | |
| Financing Cash Flow | $12M | $1M | $7M | $2M | $28M | $18M | $4M | $1M | $2.6K | $22.1K | $81M | $40M | |
| Net Change in Cash | $8M | $-3M | $-6M | $-17M | $18M | $7M | $-2M | $6M | $-3M | $-44M | · | · | |
| Free Cash Flow | · | · | · | · | $-10M | $-10M | · | · | $-28M | $-33M | $-21M | $-7M |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | -696.3% | -148.8% | -238.5% | · | -2724.7% | -3946.5% | · | · | |
| Net Margin | · | · | · | · | -693.8% | -140.5% | -200.2% | · | -2701.7% | -3907.7% | · | · | |
| EBITDA Margin | · | · | · | · | -695.2% | -148.4% | -234.8% | · | -2724.7% | -3946.5% | · | · | |
| ROA | · | -116.1% | · | -113.9% | -38.8% | -37.9% | -67.6% | · | -70.1% | -49.9% | -44.6% | -45.0% | |
| ROE | · | -251.4% | · | -234.2% | -31.4% | -34.4% | -68.3% | · | -77.9% | -52.1% | -68.0% | 245.0% |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | · | · | · | · | · | · | 5.9 | 16.1 | 32.4 | 32.1 | |
| Quick Ratio | · | · | · | · | · | · | · | · | 5.7 | 15.7 | 32.1 | 31.7 | |
| Debt / Equity | · | 0.1 | · | · | 0.0 | 0.0 | 0.0 | · | · | · | · | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.1 | 0.3 | 0.3 | · | 0.0 | 0.0 | · | · | |
| Inventory Turnover | · | · | · | · | · | · | · | · | 1.1 | 2.9 | · | · | |
| Receivables Turnover | · | · | · | · | 0.7 | 2.7 | · | · | 113.0 | 165.9 | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $1.05 | · | $4.60 | $0.86 | $0.93 | $2.35 | · | $1.64 | $3.54 | $5.86 | $-2.95 | |
| Revenue / Share | · | · | · | $0.00 | $0.04 | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | $-4.70 | · | $-8.28 | $-0.25 | · | · | · | · | · | · | · | |
| Cash / Share | · | $1.69 | · | $5.37 | $0.65 | $0.47 | $0.83 | · | $1.08 | $1.34 | $4.24 | $15.28 | |
| EPS (TTM) | $-129.10 | $-69.54 | $-30.74 | $-14.88 | $-7.72 | $-0.50 | · | · | · | · | · | · |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | · | -64.8% | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $2M | $5M | $3M | $2M | $1M | $1M | $0 | $0 | |
| Net Income TTM | $-13M | $-6M | $-13M | $-32M | $-13M | $-7M | $-7M | $-2M | $-34M | $-39M | $-29M | $-8M | |
| Market Cap | · | $40M | · | · | · | · | · | · | · | · | · | · | |
| Enterprise Value | · | $38M | · | · | · | · | · | · | · | · | · | · | |
| P/E | -0.0 | -0.4 | · | · | · | · | · | · | · | · | · | · | |
| P/B | · | 26.3 | · | · | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 0.1 | 26.3 | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | · | -8.8 | · | · | · | · | · | · | · | · | · | · | |
| EV / EBITDA | · | -6.6 | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -19892.1% | -252.0% | · | · | · | · | · | · | · | · | · | · | |
| Payout Ratio | · | · | · | · | · | 0.00% | -1.9% | · | · | · | · | · | |
| Annual Payout | · | · | · | · | · | $0 | $133.6K | $0 | · | · | · | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $227.6K | · | · | · | $0 | · | · | · | · | · | · | · | · | $0 | · | $0 | |
| R&D Expense | $1M | $749.8K | $114.4K | $61.8K | $116.4K | $75.5K | $175.3K | $137.2K | $214.4K | $243.0K | $60.0K | $1M | $2M | $4M | $5M | $4M | |
| SG&A Expense | $1M | $2M | $402.2K | $833.3K | $849.2K | $2M | $1M | $869.2K | $1M | $2M | $910.7K | $1M | $2M | $2M | $2M | $2M | |
| Operating Expenses | $3M | $2M | $9M | $895.1K | $965.6K | $2M | $1M | $1M | $1M | $2M | $970.7K | $3M | $4M | $5M | $6M | $14M | |
| Operating Income | $-3M | $-2M | $-9M | $-895.1K | $-965.6K | $-2M | $-1M | $-1M | $-1M | $-2M | $-970.7K | $-3M | $-4M | $-5M | $-6M | $-14M | |
| Net Income | $-2M | $-2M | $-9M | $-873.5K | $-957.8K | $-2M | $-1M | $-972.1K | $-1M | $-2M | $-881.8K | $-2M | $-4M | $-5M | $-6M | $-14M | |
| EPS (Basic) | $-4.46 | $-4.18 | $-125.81 | $-1.81 | $-81.21 | $-240.07 | $-52.52 | $-11.38 | $-2.37 | $-3.27 | $-11.85 | $-5.21 | $-11.45 | $-2.23 | $-2.97 | $-6.41 | |
| EPS (Diluted) | $-4.46 | $-4.18 | $-125.81 | $-1.81 | $-81.21 | $-240.07 | $-52.52 | $-11.38 | $-2.37 | $-3.27 | $-11.85 | $-5.21 | $-11.45 | $-2.23 | $-2.97 | $-6.41 | |
| Shares (Basic) | 531,968 | 531,968 | · | 481,587 | 11,794 | 7,121 | · | 85,458 | 600,417 | 524,326 | · | 469,254 | 338,638 | 2,391,964 | · | 2,247,753 | |
| Shares (Diluted) | 531,968 | 531,968 | · | 481,587 | 11,794 | 7,121 | · | 85,458 | 600,417 | 524,326 | · | 469,254 | 338,638 | 2,391,964 | · | 2,247,753 | |
| EBITDA | $-3M | $-2M | · | $-895.1K | $-965.6K | $-2M | · | $-1M | $-1M | $-2M | · | $-3M | $-4M | $-5M | · | $-14M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8M | $8M | $11M | $5M | $794.9K | $2M | $2M | $3M | $3M | $4M | $6M | $8M | $12M | $9M | $12M | $17M | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $2M | |
| Prepaid Expense | $284.2K | $537.0K | $275.2K | $1M | $564.7K | $506.7K | $553.0K | $538.6K | $241.1K | $457.1K | $619.8K | $743.2K | $284.8K | $536.6K | $803.4K | $1M | |
| Other Current Assets | $146.1K | $305.8K | $275.2K | $80.9K | $26.5K | $61.6K | $43.7K | $119.0K | $151.6K | $178.1K | $151.3K | $83.1K | $174.4K | $156.5K | $167.6K | $248.7K | |
| Current Assets | $9M | $8M | $11M | $6M | $1M | $2M | $3M | $4M | $4M | $5M | $7M | $8M | $12M | $10M | $15M | $18M | |
| PP&E (Net) | $399.1K | $35.7K | $40.6K | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Goodwill | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Other Non-current Assets | $28.8K | $29.9K | $31.0K | $32.1K | $33.2K | $34.3K | $35.4K | $36.5K | $39.9K | $53.4K | $66.8K | $80.4K | $99.0K | $114.9K | $130.5K | $146.5K | |
| Total Assets | $9M | $8M | $11M | $6M | $1M | $2M | $3M | $4M | $4M | $5M | $7M | $8M | $12M | $10M | $15M | $20M | |
| Accounts Payable | $1M | $936.0K | $940.6K | $1M | $1M | $1M | $937.0K | $165.8K | $643.1K | $714.0K | $602.9K | $1M | $2M | $4M | $3M | $2M | |
| Short-term Debt | · | · | $0 | $0 | $0 | $112.2K | $221.9K | $328.8K | $0 | $116.9K | $289.6K | $459.1K | · | · | $0 | · | |
| Current Liabilities | $5M | $5M | $5M | · | · | · | $2M | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $5M | $5M | $5M | $2M | $2M | $2M | $2M | $934.6K | $1M | $1M | $1M | $2M | $4M | $4M | $4M | $3M | |
| Total Debt | · | · | · | $0 | $0 | $112.2K | · | $328.8K | $0 | $116.9K | · | $459.1K | · | · | · | · | |
| Common Stock | $53 | $53 | $53 | $94 | $213 | $208 | $1 | $144 | $64 | $431 | $49 | $394 | $335 | $246 | $225 | $224 | |
| Paid-in Capital | $103M | $101M | $100M | $90M | $84M | $84M | $83M | $83M | $82M | $82M | $82M | $82M | $81M | $75M | $74M | $74M | |
| Retained Earnings | $-99M | $-97M | $-94M | $-85M | $-85M | $-84M | $-82M | $-80M | $-79M | $-78M | $-76M | $-75M | $-73M | $-69M | $-64M | $-57M | |
| Stockholders' Equity | $4M | $4M | $6M | $4M | $-829.7K | $61.9K | $2M | $3M | $2M | $4M | $5M | $6M | $8M | $6M | $10M | $17M | |
| Liabilities + Equity | $9M | $8M | $11M | $6M | $1M | $2M | $3M | $4M | $4M | $5M | $7M | $8M | $12M | $10M | $15M | $20M | |
| Shares Outstanding | 531,968 | 531,968 | 531,968 | 944,491 | 2,127,286 | 2,081,839 | 8,006 | 1,441,157 | 641,177 | 4,314,433 | 492,304 | 3,938,433 | 3,352,069 | 2,468,297 | 2,255,899 | 2,249,371 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $13.6K | $5.9K | $3.8K | $1.1K | $1.1K | $1.1K | $1.1K | $1.1K | $1.1K | $1.1K | $1.1K | $5.6K | $1.7K | $1.7K | $1.7K | $1.7K | |
| Stock-based Comp | $206.2K | $213.0K | $139.5K | $22.8K | $23.2K | $33.5K | $51.0K | $60.0K | $85.2K | $77.5K | $85.4K | $112.7K | $123.5K | $203.3K | $145.5K | $137.9K | |
| Other Non-cash | · | $-883.7K | · | · | · | $493.2K | · | · | · | $282.7K | · | · | · | $2M | · | · | |
| Operating Cash Flow | $-3M | $-3M | $-1M | $-2M | $-862.3K | $-1M | $-742.5K | $-1M | $-1M | $-1M | $-2M | $-4M | $-4M | $-3M | $-5M | $-6M | |
| Investing Cash Flow | · | · | $964.7K | $-200.0K | · | · | $0 | · | · | · | · | $0 | $0 | $0 | $0 | $0 | |
| Financing Cash Flow | $3M | $0 | $6M | $6M | $-141.2K | $545.6K | $-107.0K | $1M | $-28.2K | $-172.8K | $-169.4K | $-211.8K | $7M | $336.7K | $1 | $-85.7K | |
| Net Change in Cash | $468.5K | $-3M | $6M | $4M | $-1M | $-636.1K | $-849.5K | $11.2K | $-1M | $-2M | $-2M | $-4M | $2M | $-3M | $-5M | $-6M |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1155.8% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | -1042.8% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -1155.8% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| ROA | -45.7% | -41.3% | · | -17.5% | -38.7% | -47.3% | · | -15.8% | -18.2% | -23.0% | · | -17.4% | -17.0% | -23.4% | · | -45.0% | |
| ROE | -136.0% | -112.9% | · | -24.4% | -123.9% | -92.1% | · | -21.6% | -26.4% | -37.2% | · | -21.5% | -19.7% | -27.4% | · | -48.6% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | 1.8 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Quick Ratio | 1.8 | 1.7 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Debt / Equity | · | · | · | 0.0 | 0.0 | 1.8 | · | 0.1 | 0.0 | 0.0 | · | 0.1 | · | · | · | · |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $8.12 | $7.29 | · | $4.50 | $-0.39 | $0.03 | · | $2.03 | $3.70 | $0.85 | · | $1.54 | $2.51 | $2.25 | · | $7.39 | |
| Revenue / Share | $0.43 | · | · | · | · | · | · | · | · | · | · | · | · | $0.00 | · | $0.00 | |
| Cash Flow / Share | · | $-5.43 | · | · | · | $-0.71 | · | · | · | $-0.32 | · | · | · | $-1.32 | · | · | |
| Cash / Share | $15.58 | $14.70 | · | $5.09 | $0.37 | $0.86 | · | $2.28 | $5.10 | $1.01 | · | $1.92 | $3.44 | $3.76 | · | $7.48 | |
| EPS (TTM) | $-136.26 | $-213.01 | · | $-375.61 | $-385.18 | $-306.34 | · | $-28.87 | $-22.70 | $-31.78 | · | $-21.86 | $-23.06 | $-13.81 | · | $-17.41 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Net Income TTM | $-14M | $-13M | · | $-5M | $-5M | $-6M | · | $-5M | $-6M | $-9M | · | $-18M | $-30M | $-31M | · | $-29M | |
| Market Cap | $4M | $3M | · | $3M | $29M | $24M | · | $31M | $23M | $274M | · | · | · | · | · | · | |
| Enterprise Value | · | · | · | $-1M | $28M | $22M | · | $28M | $20M | $270M | · | · | · | · | · | · | |
| P/E | -0.1 | -0.0 | · | -0.0 | -0.0 | -0.0 | · | -0.7 | -1.6 | -2.0 | · | · | · | · | · | · | |
| P/B | 0.9 | 0.9 | · | 0.8 | -34.5 | 380.6 | · | 10.6 | 9.6 | 75.0 | · | · | · | · | · | · | |
| P / Tangible Book | 0.9 | 0.9 | · | 0.8 | · | 380.6 | · | 10.6 | 9.6 | 75.0 | · | · | · | · | · | · | |
| P / Cash Flow | · | -1.2 | · | · | · | -19.9 | · | · | · | -202.3 | · | · | · | · | · | · | |
| Earnings Yield | -1895.1% | -3261.5% | · | -10234.6% | -2865.9% | -2708.6% | · | -133.7% | -63.6% | -50.1% | · | · | · | · | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | · | · | · | $0 | $2M |
| Operating Margin % | · | · | · | · | -696.3% |
| Net Income | $-13M | $-6M | $-13M | $-32M | $-13M |
| Diluted EPS | $-129.10 | $-69.54 | $-30.74 | $-14.88 | $-7.72 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debt / Equity | · | 0.1 | · | · | 0.0 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | · | · | · | · | $-10M |
Institutional owners (13F)
Institutional activity — Q4 2025 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 5 | 1 | 2 | 0 | · |
Compared to Q3 2025. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair. Change vs prior quarter not shown: filer coverage differs too much between these two quarters for a reliable comparison.
Activists & 5%+ owners 10 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Elvin Lee | Oct. 27, 2023 | · | Initial filing | · | SEC |
| Undisclosed reporting person | Feb. 21, 2020 | · | Initial filing | · | SEC |
| Undisclosed reporting person | Feb. 21, 2020 | · | Initial filing | · | SEC |
| Undisclosed reporting person, Undisclosed reporting person | July 29, 2019 | · | Initial filing | · | SEC |
| Undisclosed reporting person | July 29, 2019 | · | Initial filing | · | SEC |
| Undisclosed reporting person | July 29, 2019 | · | Initial filing | · | SEC |
| Boston Foundation, Inc. (2) ×2 filings | Jan. 17, 2019 | · | Initial filing | · | SEC |
| Christoph Westphal, M.D., Ph.D. ×2 filings | Dec. 21, 2018 | · | Initial filing | · | SEC |
| Longwood Fund II, L.P., Longwood Fund III, L.P., Longwood Fund II GP, LLC, Longwood Fund III GP, LLC, Christoph Westphal, M.D., Ph.D., Richard Aldrich ×3 filings | Oct. 26, 2018 | · | Initial filing | · | SEC |
| Longwood Fund II, L.P. (2), Longwood Fund II GP, LLC (2), Christoph Westphal, M.D., Ph.D. (2), Richard Aldrich (2), Michelle Dipp, M.D., Ph.D. (2) | Feb. 19, 2015 | · | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 33 insiders · 13 officers · 18 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Frederick Pierce II | Chief Executive Officer | Aug. 31, 2026 A | 34,844 | 0 | 0 | $0 |
| David J. Arthur | Chief Executive Officer | April 11, 2024 A | 48,019 | 0 | 0 | $0 |
| Mark J Rosenblum | Chief Financial Officer | Aug. 31, 2026 A | 11,363 | 1 | 0 | $16,000 |
| John P. Mccabe | Chief Financial Officer | June 14, 2018 A | 1,650 | 0 | 0 | $0 |
| Marina Hahn | President, Consumer | Nov. 11, 2015 A | · | 0 | 0 | $0 |
| Katharine Lindemann | Chief Operating Officer | Jan. 18, 2017 A | · | 0 | 0 | $0 |
| Marschel Peter Klaus | Chief Business Officer | Aug. 31, 2026 A | 3,900 | 0 | 0 | $0 |
| Barbara Louise Hibner | Chief Scientific Officer | Aug. 31, 2026 A | 4,216 | 0 | 0 | $0 |
| Scott Jordan | Chief Business Officer | Feb. 18, 2020 P | 31,609 | 0 | 0 | $0 |
| Pao-Yu Chuang | Controller | Sept. 10, 2019 A | · | 0 | 0 | $0 |
| Elizabeth Woo | SVP, Investor Relations | Jan. 17, 2018 A | · | 0 | 0 | $0 |
| Thomas Wessel | Chief Medical Officer | Jan. 17, 2018 A | 57,064 | 0 | 0 | $0 |
| Robert Hadfield | General Counsel & Secretary | Jan. 18, 2017 A | · | 0 | 0 | $0 |
| Patricia G. Gauthier | Director | Aug. 31, 2026 A | 2,000 | 0 | 0 | $0 |
| Tess Burleson | Director | Aug. 31, 2026 A | 2,002 | 0 | 0 | $0 |
| William K. Mcvicar | Director | Aug. 31, 2026 A | 3,002 | 0 | 0 | $0 |
| Paul Lammers | Director | Aug. 31, 2026 A | 2,001 | 0 | 0 | $0 |
| Jonathan I Lieber | Director | Aug. 31, 2026 A | 2,002 | 0 | 0 | $0 |
| Arnold C Hanish | Director | Aug. 31, 2026 A | 3,418 | 1 | 2 | $3,732 |
| Bruce J Mccreedy Jr. | Director | Feb. 20, 2024 A | 1,788 | 0 | 0 | $0 |
| Jonathan P Northrup | Director | March 23, 2020 A | 352,713 | 0 | 0 | $0 |
| Roger D Tung | Director | July 25, 2018 A | · | 0 | 0 | $0 |
| Michelle Stacy | Director | July 25, 2018 A | 2,585 | 0 | 0 | $0 |
| Stuart A Randle | Director | July 25, 2018 A | · | 0 | 0 | $0 |
| Marc D Kozin | Director | July 25, 2018 A | 4,500 | 0 | 0 | $0 |
| Peter Barton Hutt | Director | July 25, 2018 A | 11,675 | 0 | 0 | $0 |
| Roderick Mackinnon | Director | July 26, 2017 A | 431,277 | 0 | 0 | $0 |
| Robert J Perez | Director | July 26, 2017 A | · | 0 | 0 | $0 |
| Jeffrey D Capello | Director | July 26, 2017 A | · | 0 | 0 | $0 |
| SCULLEY JOHN | Director | March 21, 2016 P | 4,709 | 0 | 0 | $0 |
| Boston Foundation, Inc. | 10% owner | Jan. 9, 2019 S | 1,600,000 | 0 | 0 | $0 |
| Longwood Fund II, L.P. | 10% owner | Oct. 16, 2018 S | 0 | 0 | 0 | $0 |
| Christoph H Westphal | 10% owner | Oct. 16, 2018 S | 0 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 1 ETF
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0.00% | 4,034 SH | Aug. 19, 2026 | Daily |
DCOY Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 6 analysts
SELL
Median target
$3.00
+69.5%
0 0.0%
Strong Buy
0 0.0%
Buy
3 50.0%
Hold
1 16.7%
Sell
2 33.3%
Strong Sell
12-Month Price Target
1 analysts · 2026-10-02Mean target $3.00 +69.5%
Low$3.00
Mean$3.00
High$3.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 12, 2026